Ledger.Open graph →
SEC Form D · filed May 30, 2014

Chase Pharmaceuticals Corp

Offering
$8.6M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WASHINGTON, Washington, D.C.
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Robert Moore · Chicago, ILDirectorAdamas Capital Management, LP · Boston, MADirectorPatty White · COLUMBUS, OHDirectorPeter Anadranistakis · Scottsdale, AZDirectorJoseph C. Robillard · Berkeley Heights, NJDirectorTimothy C. Klag · Berkeley Heights, NJExec · DirectorJoseph C. Robillard · Berkeley Heights, NJDirectorMichael Wilde · Chicago, ILDirectorMichela Wilde · Chicago, ILDirectorLisa A. Arington-Glesinger · Cottage Grove, WIExec · DirectorGreg N. Parekh · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗